Sun Pharma and Rohto Recall Eye Drops Over Sterility Concerns in India and US
Sun Pharma has recalled multiple eye drop products in India due to contamination concerns, urging distributors to halt sales and return existing stocks as a precaution. The company emphasized patient safety and regulatory compliance. Separately, the US FDA announced a voluntary Class II recall of nearly 12 million Rohto Cooling Eye Drops bottles over sterility concerns, advising consumers to check product details and stop use if affected. Both recalls highlight the importance of sterility in eye care products to prevent health risks.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 55/100.
Outlets measured: thefinancialexpress, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 1 Aug, 02:02 pm. Other outlets followed.
- 1